StockData
ISCOOTCPharmaceutical PreparationsFiscal year ends December 31

International Stem Cell CORP

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.28+0.00 (+0.89%)

Close on Oct 19, 2026

Market cap
$2.27M
P/E (TTM)
–
Dividend yield
–

Earnings

Quarterly results announced on Form 8-K, Item 2.02

QuarterReportedTimeRevenueEPS (GAAP)EPS (adjusted)
Q1 FY2015
Ended Mar 31, 2015
Apr 1, 2015During market hours–––
Q3 FY2014
Ended Sep 30, 2014
Nov 13, 2014Before market open–––
Q2 FY2014
Ended Jun 30, 2014
Aug 12, 2014Before market open–––
Q1 FY2014
Ended Mar 31, 2014
May 13, 2014Before market open–––
Q4 FY2013
Ended Dec 31, 2013
Mar 18, 2014Before market open–––
Q3 FY2013
Ended Sep 30, 2013
Nov 13, 2013Before market open–––
Q2 FY2013
Ended Jun 30, 2013
Aug 8, 2013Before market open–––
Q1 FY2013
Ended Mar 31, 2013
May 14, 2013Before market open–––
Q4 FY2012
Ended Dec 31, 2012
Mar 27, 2013Before market open–––
Q3 FY2012
Ended Sep 30, 2012
Nov 9, 2012During market hours–––
Q2 FY2012
Ended Jun 30, 2012
Aug 9, 2012Before market open–––
Q4 FY2011
Ended Dec 31, 2011
Mar 22, 2012During market hours–––

Press releases

Announcements International Stem Cell filed with the SEC